GBS(INBS)

Search documents
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
GlobeNewswire News Room· 2024-06-27 12:30
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the expansion of its customer network within the UK retail sector. This includes the adoption of INBS' Intelligent Fingerprinting Drug Screening System by three prominent UK retailers, among the largest and most recognized in the country. The recently secured accounts employ over 55,000 ...
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
Newsfilter· 2024-06-20 12:30
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has successfully signed two new major customer accounts within the UK warehouse and logistics sector within the past three months. These accounts employ more than 15,000 individuals at more than 70 locations and will adopt INBS' innovative Intelligent Fingerprinting Drug Screenin ...
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Newsfilter· 2024-06-18 12:30
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is entering the next phase of its planned 510(k) submission to the FDA. The Company has successfully completed subject screening for its Pharmacokinetic (PK) Study and will begin dosing and sampling study subjects today. INBS' PK study is a key step towards the Company's planned ...
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
Newsfilter· 2024-06-13 12:30
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the implementation of a strategic and comprehensive reorganization and productivity plan to support the Company's global growth initiatives. Harry Simeonidis, President and CEO at INBS, commented, "This strategic realignment will refocus priorities to better serve our global markets, enh ...
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
Newsfilter· 2024-06-12 12:30
Company Overview - Intelligent Bio Solutions Inc. (NASDAQ:INBS) is a medical technology company focused on delivering innovative, rapid, non-invasive testing solutions [5] - The company’s Intelligent Fingerprinting Drug Screening System utilizes fingerprint sweat analysis for drug testing, which is designed to be hygienic and cost-effective [5][11] Recent Developments - INBS has added a major European transport and infrastructure solutions provider to its client base, indicating growing interest in its technology within the transport and infrastructure sectors [3][8] - The new client will use INBS' Intelligent Fingerprinting Drug Screening System to monitor employee fitness for duty in the UK [3][4] Technology and Benefits - The Intelligent Fingerprinting Drug Screening System allows for quick, in-house drug testing, providing results in under ten minutes, which enhances operational efficiency and workplace safety [4][11] - The system screens for common workplace drugs, including opiates, cocaine, methamphetamine, and cannabis, making it a valuable tool for safety-critical industries [5][11] Market Position and Strategy - The addition of the new client follows a long-term relationship with an existing account in the same sector, demonstrating INBS' ability to establish enduring supply relationships [8] - The company is gaining traction across various industries, including construction, manufacturing, engineering, transport, logistics, and drug treatment organizations [5][8]
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
Newsfilter· 2024-06-06 12:30
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024. Presentation Details Date: Wednesday, June 12, 2024 Time: 4:00 p.m. Eastern Time Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_BB5QumW3TK2N56X7MOPj ...
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
GlobeNewswire News Room· 2024-06-06 12:30
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine ...
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
Newsfilter· 2024-05-29 12:30
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful recruitment and commencement of screening for subjects in its pharmacokinetic (PK) study, a critical component of the Company's FDA 510(k) regulatory pathway for clearance. Harry Simeonidis, President and CEO at INBS, commented, "As we navigate the FDA 510(k) regulatory pa ...
Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective Solutions
Newsfilter· 2024-05-23 12:30
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today unveiled key performance indicators from its United Kingdom operations. These indicators have contributed to the Company's growth as the drug screening industry continues to combat drug test cheating and searches for simpler, faster, non-invasive, and more cost-effective solutions. For the nine mo ...
Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective Solutions
globenewswire.com· 2024-05-23 12:30
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today unveiled key performance indicators from its United Kingdom operations. These indicators have contributed to the Company's growth as the drug screening industry continues to combat drug test cheating and searches for simpler, faster, non-invasive, and more cost-effective solutions. For the nine mo ...